Tiv Taam Holdings 1 Ltd
Tiv Taam Holdings 1 Ltd operates as a food and drug retailer, generating revenue primarily through the sale of groceries, household goods, and pharmaceutical products.
Business. Tiv Taam Holdings 1 Ltd (TTAM.TA) is a food and drug retailer operating within the Consumer Non-Cyclicals sector. The company is headquartered in Israel and is primarily listed on the Tel Aviv Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Tiv Taam Holdings 1 Ltd (TTAM.TA) is a food and drug retailer operating within the Consumer Non-Cyclicals sector. The company is headquartered in Israel and is primarily listed on the Tel Aviv Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Tiv Taam Holdings 1 Ltd maintains a capital structure with a debt-to-equity ratio of 1.89, indicating a relatively high leverage position compared to industry norms. The company's liquidity is assessed as medium, with a current ratio of 0.9, suggesting limited short-term liquidity to cover current liabilities. Free cash flow stands at 79.63 million ILS, but net cash is negative after subtracting total debt, signaling potential liquidity constraints.
Profitability metrics show a return on equity (ROE) of 19%, which is strong, but return on assets (ROA) is at 4.75%, below the typical performance of industry peers. The company's operating income of 122.48 million ILS and net income of 73.32 million ILS reflect a healthy gross margin of 33.7%, but the ROA suggests underutilization of assets to generate returns.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. The company's operations are entirely within its home market, with no international revenue streams reported.
Looking ahead, the company is projected to maintain a stable revenue trajectory, with no significant growth or contraction expected in the next fiscal year. Capital expenditures of -97.41 million ILS indicate a reduction in investment, which may signal a focus on cost control rather than expansion. The company's operating cash flow of 229.84 million ILS supports its current operations but does not provide a buffer for unexpected downturns.
Risk factors include medium liquidity risk and a high debt load, which could constrain the company's ability to respond to market changes. Dilution risk is assessed as low, with no near-term pressure from share issuance. However, the company's reliance on a single business model and geographic market increases vulnerability to sector-specific shocks.
Recent events include analyst estimates indicating a mean price target of 13.40 ILS, with a median of 13.40 ILS and a range from 11.80 to 15.00 ILS. Analysts have issued two "buy" recommendations and no "strong buy" or "hold" ratings, suggesting a cautiously optimistic outlook.
- Tiv Taam Holdings 1 Ltd has a strong ROE of 19% but a weak ROA of 4.75%, indicating underutilized assets.
- The company's debt-to-equity ratio of 1.89 suggests a high leverage position, increasing financial risk.
- Free cash flow of 79.63 million ILS is positive but insufficient to cover total debt, raising liquidity concerns.
- Analysts project a mean price target of 13.40 ILS, with a "buy" consensus, but no strong buy ratings.
- The company's lack of geographic and segment diversification increases exposure to regional and sector-specific risks.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | —no estimate |
| Revenue | —no estimate | —no estimate | 2,0B ILS |
| Operating income | —no estimate | —no estimate | 146,5M ILS |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Units - 2026 Grant → Common StockAcquired 5 880grant · 2026-05-05
- Director · Restricted Stock Units - 2026 Grant → Common StockAcquired 2 014grant · 2026-05-05
- Director · Restricted Stock Units - 2026 Grant → Common StockAcquired 5 880grant · 2026-05-05
- Director · Restricted Stock Units - 2026 Grant → Common StockAcquired 5 880grant · 2026-05-05
- President, Titan Mid-Atlantic · Restricted Stock Units - 2026 Grant → Common StockAcquired 13 681grant · 2026-04-01
- Chief Human Resources Officer · Restricted Stock Units - 2026 Grant → Common StockAcquired 9 785grant · 2026-04-01
- Chief Financial Officer · Restricted Stock Units - 2026 Grant → Common StockAcquired 10 921grant · 2026-04-01
- Chief Accounting Officer · Restricted Stock Units - 2026 Grant → Common StockAcquired 8 149grant · 2026-04-01
- Chief Legal Counsel · Restricted Stock Units - 2026 Grant → Common StockAcquired 13 454grant · 2026-04-01
- President, Titan Florida · Restricted Stock Units - 2026 Grant → Common StockAcquired 17 641grant · 2026-04-01
- Director, President and CEO · Restricted Stock Units - 2026 Grant → Common StockAcquired 34 610grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 5 849exercise · 2026-03-31
- Director · Restricted Stock Units → Common StockDisposed 5 849exercise · 2026-03-31
- Director · Restricted Stock Units → Common StockDisposed 5 849exercise · 2026-03-31
- Director · Restricted Stock Units → Common StockDisposed 5 849exercise · 2026-03-31
Physical assets
2 tracked| Asset | Type | Commodity | Country | Role |
|---|---|---|---|---|
| Pennusco Cement Plant | Cement plant | Cement | United States | Registered owner |
| Roanoke Cement Plant | Cement plant | Cement | United States | Registered owner |
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Tiv Taam Holdings 1 Ltd Market data — financials · 2026-05-29
- Tiv Taam Holdings 1 Ltd Market data — analyst estimates · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$4M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Director · Common StockOther 3 130 @ $15,46$48K · 2026-05-18
- Director · Common StockOther 3 130 @ $15,46$48K · 2026-05-18
- Director · Common StockOther 3 130 @ $15,46$48K · 2026-05-18
- Director · Common StockOther 3 130 @ $15,46$48K · 2026-05-18
- Chief Financial Officer · Common StockOther 48 @ $16,56$800 · 2026-05-11
- Director · Common StockOther 5 849 · 2026-03-31
- Director · Common StockOther 5 849 · 2026-03-31
- Director · Common StockOther 5 849 · 2026-03-31
- Director · Common StockOther 5 849 · 2026-03-31
- Chief Financial Officer · Common StockBought 20 000 @ $14,93$299K · 2026-03-19